DNA · ISSUER CIK 1830214
Ginkgo Bioworks Holdings, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 5 Ginkgo Bioworks Holdings, Inc. insiders reported $0.00 of open-market purchases and $1.4M of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 1 of 7 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.4MInsider selling
−$1.4MNet open-market
Oct 21, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 21, 202616:07 | Oct 19, 2026 | DNA | See remarks | S · Sell | $10.14 | −766 | 50,168 | -2% | −$8K | ||
| Oct 21, 202616:07 | Oct 16, 2026 | DNA | See remarks | M · ExerciseLate 5d | — | +1,486 | 50,934 | +3% | — | ||
| Oct 21, 202616:06 | Oct 19, 2026 | DNA | 10% Owner | S · Sell | $10.14 | −41,172 | 356,329 | -10% | −$418K | ||
| Oct 21, 202616:06 | Oct 16, 2026 | DNA | 10% Owner | M · ExerciseLate 5d | — | +76,462 | 375,132 | +26% | — | ||
| Oct 21, 202616:06 | Oct 19, 2026 | DNA | See remarks, Director, 10% Owner | S · Sell | $10.14 | −41,172 | 453,951 | -8% | −$418K | ||
| Oct 21, 202616:06 | Oct 16, 2026 | DNA | See remarks, Director, 10% Owner | M · ExerciseLate 5d | — | +76,462 | 476,320 | +19% | — | ||
| Oct 21, 202616:05 | Oct 19, 2026 | DNA | See remarks, Director | S · Sell | $10.14 | −45,682 | 129,065 | -26% | −$463K | ||
| Oct 21, 202616:05 | Oct 16, 2026 | DNA | See remarks, Director | M · ExerciseLate 5d | — | +81,484 | 174,747 | +87% | — | ||
| Oct 7, 202617:00 | Oct 5, 2026 | DNA | See remarks | S · Sell10b5-1 | $15.00 | −2,403 | 49,448 | -5% | −$36K | ||
| Sep 16, 202616:06 | Sep 15, 2026 | DNA | Director | S · Sell | $7.08 | −5,000 | 19,310 | -21% | −$35K | ||
| Aug 25, 202617:01 | Aug 24, 2026 | DNA | See remarks | S · Sell | $6.98 | −330 | 51,851 | -1% | −$2K | ||
| Aug 25, 202617:01 | Aug 21, 2026 | DNA | See remarks | M · Exercise | — | +743 | 52,181 | +1% | — |